Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Mast cell activation syndrome: Proposed diagnostic criteria.

Akin C, Valent P, Metcalfe DD.

J Allergy Clin Immunol. 2010 Dec;126(6):1099-104.e4. doi: 10.1016/j.jaci.2010.08.035. Epub 2010 Oct 28.

2.

Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines.

Aung G, Niyonsaba F, Ushio H, Kajiwara N, Saito H, Ikeda S, Ogawa H, Okumura K.

Immunology. 2011 Apr;132(4):527-39. doi: 10.1111/j.1365-2567.2010.03395.x. Epub 2011 Jan 7.

3.

Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a.

Woolhiser MR, Brockow K, Metcalfe DD.

Clin Immunol. 2004 Feb;110(2):172-80.

PMID:
15003814
4.

Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells.

Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M.

Allergy. 2006 Dec;61(12):1473-9.

5.

Mast cell activation syndrome: a review.

Frieri M, Patel R, Celestin J.

Curr Allergy Asthma Rep. 2013 Feb;13(1):27-32. doi: 10.1007/s11882-012-0322-z. Review.

PMID:
23179866
6.

Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.

Picard M, Giavina-Bianchi P, Mezzano V, Castells M.

Clin Ther. 2013 May;35(5):548-62. doi: 10.1016/j.clinthera.2013.04.001. Epub 2013 May 1. Review.

PMID:
23642289
7.

Assay of mast cell mediators.

Rådinger M, Jensen BM, Swindle E, Gilfillan AM.

Methods Mol Biol. 2015;1220:307-23. doi: 10.1007/978-1-4939-1568-2_19.

PMID:
25388259
8.

Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.

Ravi A, Butterfield J, Weiler CR.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):775-8. doi: 10.1016/j.jaip.2014.06.011. Epub 2014 Nov 6.

PMID:
25439370
9.

Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations.

Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ.

J Allergy Clin Immunol. 2011 Jul;128(1):147-152.e2. doi: 10.1016/j.jaci.2011.04.037. Epub 2011 May 28.

PMID:
21621255
10.

Ginkgetin, a Biflavone from Ginko biloba leaves, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells.

Son JK, Son MJ, Lee E, Moon TC, Son KH, Kim CH, Kim HP, Kang SS, Chang HW.

Biol Pharm Bull. 2005 Dec;28(12):2181-4.

11.

Nitric Oxide positively regulates Ag (I)-induced Ca(2+) influx and mast cell activation: role of a Nitric Oxide Synthase-independent pathway.

Inoue T, Suzuki Y, Yoshimaru T, Ra C.

J Leukoc Biol. 2009 Dec;86(6):1365-75. doi: 10.1189/jlb.0609387. Epub 2009 Aug 25.

PMID:
19706839
12.

Mast cell activation syndromes: definition and classification.

Valent P.

Allergy. 2013 Apr;68(4):417-24. doi: 10.1111/all.12126. Epub 2013 Feb 15. Review.

13.

Spectrum of mast cell activation disorders.

Petra AI, Panagiotidou S, Stewart JM, Conti P, Theoharides TC.

Expert Rev Clin Immunol. 2014 Jun;10(6):729-39. doi: 10.1586/1744666X.2014.906302. Epub 2014 May 1. Review.

PMID:
24784142
14.

Oxidative stress potentially enhances FcεRI-mediated leukotriene C4 release dependent on the late-phase increase of intracellular glutathione in mast cells.

Seki K, Hisada T, Kawata T, Kamide Y, Dobashi K, Yamada M, Mori M, Okajima F, Ishizuka T.

Biochem Biophys Res Commun. 2013 Sep 27;439(3):357-62. doi: 10.1016/j.bbrc.2013.08.081. Epub 2013 Aug 30.

PMID:
23998930
16.

Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity.

Haberl C, Hültner L, Flügel A, Falk M, Geuenich S, Wilmanns W, Denzlinger C.

Mediators Inflamm. 1998;7(2):79-84.

17.

A differential role for ceramide kinase in antigen/FcɛRI-mediated mast cell activation and function.

Hewson CA, Watson JR, Liu WL, Fidock MD.

Clin Exp Allergy. 2011 Mar;41(3):389-98. doi: 10.1111/j.1365-2222.2010.03682.x. Epub 2011 Jan 24.

PMID:
21255156
18.

Prolonged culture of mast cells with high-glucose medium enhances the Fc epsilon RI-mediated degranulation response and leukotriene C4 production.

Kitahata Y, Nunomura S, Terui T, Ra C.

Int Arch Allergy Immunol. 2010;152 Suppl 1:22-31. doi: 10.1159/000312122. Epub 2010 Jun 4.

PMID:
20523060
19.
20.

[NON-CLONAL MAST CELL ACTIVATION SYNDROME: DESCRIPTION OF SERIES OF PATIENTS, DIAGNOSTIC CRITERIA AND TREATMENT].

Confino-Cohen R, Mekori YA.

Harefuah. 2015 Aug;154(8):507-9, 540. Hebrew.

PMID:
26480615

Supplemental Content

Support Center